Martin Radvan
Impact in
-
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Nosocomial Infections in ICU
-
- Acute Kidney Injury Research
Papers in
-
- Heart Failure Treatment and Management 3
- Cardiovascular Effects of Exercise 1
-
- Venous Thromboembolism Diagnosis and Management 2
- Co-authors
- Peter Scheer (4 shared papers)Ilona Kantorová (3 shared papers)Petr Svoboda (2 shared papers)J. Doubek (1 shared paper)Petr Kala (4 shared papers)Jan Kaňovský (1 shared paper)Jitka Řehořová (1 shared paper)Martin Poloczek (2 shared papers)
In The Last Decade
Martin Radvan
15 papers receiving 248 citations
Martin Radvan's Hit Papers
Peers
Comparison fields: 5 of 48
- Critical Care and Intensive Care Medicine 56
- Nephrology 24
- Applied Microbiology and Biotechnology 6
- Epidemiology 92
- Gastroenterology 14
Countries citing papers authored by Martin Radvan
This map shows the geographic impact of Martin Radvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Radvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Radvan more than expected).
Fields of papers citing papers by Martin Radvan
This network shows the impact of papers produced by Martin Radvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Radvan. The network helps show where Martin Radvan may publish in the future.
Co-authors
The 25 scholars most cited alongside Martin Radvan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery? | 2007 | 62 |
| 2 | 2012 | 34 | |
| 3 | Therapeutic influence of 20 % albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial. | 2010 | 32 |
| 4 | Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial Hit paper breakdown → | 2025 | 30 |
| 5 | 2022 | 25 | |
| 6 | 2020 | 22 | |
| 7 | Brain natriuretic peptide in decompensation of liver cirrhosis in non-cardiac patients. | 2009 | 18 |
| 8 | 2011 | 14 | |
| 9 | 2025 | 14 | |
| 10 | 2022 | 8 | |
| 11 | 2022 | 4 | |
| 12 | 1987 | 4 | |
| 13 | 2025 | 3 | |
| 14 | 2017 | 1 | |
| 15 | 2021 | 1 | |
| 16 | 2026 | 0 | |
| 17 | 2026 | 0 | |
| 18 | 2024 | 0 |
About Martin Radvan
Martin Radvan is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Neurology, Epidemiology and Nephrology, having authored 18 papers that have together received 272 indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (3 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Long-Term Effects of COVID-19 (2 papers), Sepsis Diagnosis and Treatment (2 papers), Cardiovascular Effects of Exercise (1 paper), Infective Endocarditis Diagnosis and Management (1 paper), Lanthanide and Transition Metal Complexes (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Critical Care and Intensive Care Medicine (56 citations), Nephrology (24 citations), Applied Microbiology and Biotechnology (6 citations), Epidemiology (92 citations) and Gastroenterology (14 citations). Martin Radvan has collaborated with scholars based in Czechia and Slovakia. Frequent co-authors include Peter Scheer, Ilona Kantorová, Petr Svoboda, J. Doubek, Petr Kala, Jan Kaňovský, Jitka Řehořová, Martin Poloczek, Roman Štípal and Martin Hudec. Their work appears in journals such as Frontiers in Cardiovascular Medicine, The Lancet, EuroIntervention, JACC Heart Failure and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.